Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2026-05-05 @ 1:36 PM
Study NCT ID:
NCT00017316
Status:
COMPLETED
Last Update Posted:
2013-02-11
First Post:
2001-06-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
CDR0000068677
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None